Julius Knowles, Director of Keros Therapeutics KROS, has filed 1 purchase and 1 sale on the open market. Over the past 12 months that comes to a net sale of $28.2K. The latest trade was on 06/04.

JK

JK

Julius Knowles

Director

Company

Keros Therapeutics KROS

First filing

23/01/20

Trades

10 trades

Buys / sales

1 / 1

12-month net buying

−$28.2K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale10b5-1 plan	06/04	06/08	2,625 sh	$10.73	$28,166.25	−19.3%
Keros TherapeuticsKROS	Open-market buy	20/04/13	23/01/20	1,191 sh	$20.98	$24,987.18	No record